SpyGlass Pharma SGP
NASDAQ SGP
$27.74 +0.03 (+0.09%)
As of: Oct 22, 2026 · 10:28 AM EDT

SpyGlass Pharma (SGP) Ending Cash Balance (2024 - 2026)

Updated

Analysis

SpyGlass Pharma (SGP) Ending Cash Balance (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Ending Cash Balance (Qtr)
1 Eli Lilly 1,164.36 Bn 1,132.95 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 634.54 Bn 553.07 Bn 17.26 Bn 20.42 Bn
3 AbbVie 502.85 Bn 475.96 Bn 12.70 Bn 6.57 Bn
4 Merck 376.50 Bn 330.88 Bn 12.21 Bn 6.89 Bn
5 Novartis Ag 303.65 Bn 267.64 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 266.62 Bn 240.30 Bn 12.86 Bn 4.88 Bn
7 Amgen 241.17 Bn 196.57 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 193.39 Bn 167.59 Bn 6.22 Bn 3.18 Bn
9 Pfizer 172.45 Bn 119.10 Bn 10.94 Bn 1.03 Bn
10 SpyGlass Pharma 927.45 Mn 927.45 Mn - 223.14 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 223.14 Mn
Dec 31, 2025 96.36 Mn
Jun 30, 2025 127.24 Mn
Dec 31, 2024 16.27 Mn
API Access

SpyGlass Pharma Ending Cash Balance API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=SGP&period=max&api_key=YOUR_API_KEY